Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Use of Eltrombopag in Improving Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.

Master S, Dwary A, Mansour R, Mills GM, Koshy N.

Case Rep Oncol. 2018 Mar 27;11(1):191-195. doi: 10.1159/000487229. eCollection 2018 Jan-Apr.

2.

The effect of sepsis and septic shock on the viscoelastic properties of clot quality and mass using rotational thromboelastometry: A prospective observational study.

Davies GR, Lawrence M, Pillai S, Mills GM, Aubrey R, Thomas D, Williams R, Morris K, Evans PA.

J Crit Care. 2018 Apr;44:7-11. doi: 10.1016/j.jcrc.2017.09.183. Epub 2017 Oct 2.

PMID:
28988002
3.

Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant.

Master S, Leary C, Takalkar A, Coltelingam J, Mansour R, Mills GM, Koshy N.

Case Rep Oncol. 2017 Jun 19;10(2):534-541. doi: 10.1159/000477338. eCollection 2017 May-Aug.

4.

The effect of sepsis and its inflammatory response on mechanical clot characteristics: a prospective observational study.

Davies GR, Pillai S, Lawrence M, Mills GM, Aubrey R, D'Silva L, Battle C, Williams R, Brown R, Thomas D, Morris K, Evans PA.

Intensive Care Med. 2016 Dec;42(12):1990-1998. doi: 10.1007/s00134-016-4496-z. Epub 2016 Sep 3.

PMID:
27592210
5.

Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment.

El-Osta H, Shahid K, Mills GM, Peddi P.

Onco Targets Ther. 2016 Aug 16;9:5101-16. doi: 10.2147/OTT.S111209. eCollection 2016. Review.

6.

Effect of Payer Status on Relative Survival of Patients with Laryngeal Cancer.

Mehta V, Shi Z, Mills GM, Nathan CA, Shi R.

Anticancer Res. 2016 Jan;36(1):327-33.

PMID:
26722061
7.

The Shreveport Myeloma Experience: Survival, Risk Factors and Other Malignancies in the Age of Stem Cell Transplantation.

Munker R, Shi R, Nair B, Devarakonda S, Cotelingam JD, McLarty J, Mills GM, Glass J.

Acta Haematol. 2016;135(3):146-55. doi: 10.1159/000440970. Epub 2015 Nov 21.

PMID:
26588024
8.

Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: results of the WFU CCOP Research Base Protocol 97106.

Greven KM, Case LD, Nycum LR, Zekan PJ, Hurd DD, Balcueva EP, Mills GM, Zon R, Flynn PJ, Biggs D, Shaw EG, Lesser G, Naughton MJ.

J Community Support Oncol. 2015 Mar;13(3):87-94. doi: 10.12788/jcso.0114.

9.

Tolosa-hunt syndrome in double-hit lymphoma.

Peddi P, Gallagher KM, Chandrasekharan C, Wang Q, Gonzalez-Toledo E, Nair BS, Munker R, Mills GM, Koshy NV.

Case Rep Oncol Med. 2015;2015:249891. doi: 10.1155/2015/249891. Epub 2015 Mar 30.

10.

Development and validation of a clinical score for predicting risk of adenoma at screening colonoscopy.

Shaukat A, Church TR, Shanley R, Kauff ND, O'Brien MJ, Mills GM, Jordan PA, Allen JA, Kim A, Feld AD, Zauber AG, Winawer SJ.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):913-20. doi: 10.1158/1055-9965.EPI-14-1321. Epub 2015 Mar 23.

11.

Cisplatin, cetuximab, and radiation in locally advanced head and neck squamous cell cancer: a retrospective review.

Peddi P, Shi R, Nair B, Ampil F, Mills GM, Jafri SH.

Clin Med Insights Oncol. 2015 Jan 4;9:1-7. doi: 10.4137/CMO.S18682. eCollection 2015.

12.

The role of whole blood impedance aggregometry and its utilisation in the diagnosis and prognosis of patients with systemic inflammatory response syndrome and sepsis in acute critical illness.

Davies GR, Mills GM, Lawrence M, Battle C, Morris K, Hawkins K, Williams PR, Davidson S, Thomas D, Evans PA.

PLoS One. 2014 Sep 30;9(9):e108589. doi: 10.1371/journal.pone.0108589. eCollection 2014.

13.

Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects.

Martínez E, Yoshihara K, Kim H, Mills GM, Treviño V, Verhaak RG.

Oncogene. 2015 May 21;34(21):2732-40. doi: 10.1038/onc.2014.216. Epub 2014 Aug 4.

14.

Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.

Guo Y, Jones D, Palmer JL, Forman A, Dakhil SR, Velasco MR, Weiss M, Gilman P, Mills GM, Noga SJ, Eng C, Overman MJ, Fisch MJ.

Support Care Cancer. 2014 May;22(5):1223-31. doi: 10.1007/s00520-013-2075-1. Epub 2013 Dec 22.

15.

Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma.

Stiff PJ, Unger JM, Cook JR, Constine LS, Couban S, Stewart DA, Shea TC, Porcu P, Winter JN, Kahl BS, Miller TP, Tubbs RR, Marcellus D, Friedberg JW, Barton KP, Mills GM, LeBlanc M, Rimsza LM, Forman SJ, Fisher RI.

N Engl J Med. 2013 Oct 31;369(18):1681-90. doi: 10.1056/NEJMoa1301077.

16.

Superwarfarin intoxication: two case reports and review of pathophysiology and patient management.

Watson KS, Mills GM, Burton GV.

J La State Med Soc. 2012 Mar-Apr;164(2):70-2.

PMID:
22685854
17.

Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions.

Chu DZ, Hussey MA, Alberts DS, Meyskens FL Jr, Fenoglio-Preiser CM, Rivkin SE, Mills GM, Giguere JK, Blanke CD, Goodman GE.

Clin Colorectal Cancer. 2011 Dec;10(4):310-6. doi: 10.1016/j.clcc.2011.06.005. Epub 2011 Jul 22.

18.

Phase II evaluation of early oral estramustine, oral etoposide, and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group S0032.

Smith DC, Tangen CM, Van Veldhuizen PJ Jr, Harrer GW, Golshayan A, Mills GM, Vogelzang NJ, Thompson IM, Hussain MH.

Urology. 2011 May;77(5):1172-6. doi: 10.1016/j.urology.2010.12.043. Epub 2011 Feb 21.

19.

Metastatic malignant melanoma in a patient with Hodgkin's lymphoma in remission.

Peddi P, Slay LE, Lilien DL, Fowler MR, Cotelingam J, Veillon DM, Ayirookuzhi S, Koshy N, Mills GM, Munker R.

J La State Med Soc. 2010 Jan-Feb;162(1):47-50. No abstract available.

PMID:
20336959
20.

Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma.

Ekshyyan O, Mills GM, Lian T, Amirghahari N, Rong X, Lowery-Nordberg M, Abreo F, Veillon DM, Caldito G, Speicher L, Glass J, Nathan CO.

Head Neck. 2010 Dec;32(12):1619-28. doi: 10.1002/hed.21374.

PMID:
20222045
21.

Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer.

Sequist LV, Fidias PM, Temel JS, Kolevska T, Rabin MS, Boccia RV, Burris HA, Belt RJ, Huberman MS, Melnyk O, Mills GM, Englund CW, Caldwell DC, Keck JG, Meng L, Jones M, Brown GL, Edelman MJ, Lynch TJ.

J Thorac Oncol. 2009 Nov;4(11):1389-96. doi: 10.1097/JTO.0b013e3181b6b84b.

23.

Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426).

Sartor AO, Tangen CM, Hussain MH, Eisenberger MA, Parab M, Fontana JA, Chapman RA, Mills GM, Raghavan D, Crawford ED; Southwest Oncology Group.

Cancer. 2008 Jun;112(11):2393-400. doi: 10.1002/cncr.23473.

24.

Taking your board to the next level: a conversation with eight philanthropy board leaders.

Hurt G, Mills GM, Burress R, Ulvila L, Law J, Smith D, Garibaldi M, Ziegler J.

AHP J. 2007 Fall:8-9, 11, 13 passim. No abstract available.

PMID:
17929374
25.

Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.

Hesketh PJ, Chansky K, Israel V, Grapski RT, Mekhail TM, Spiridonidis CH, Mills GM, Kelly K, Crowley JJ, Gandara DR.

J Thorac Oncol. 2007 May;2(5):440-4.

26.

Treatment of elderly non-small cell lung cancer patients with three different schedules of weekly paclitaxel in combination with carboplatin: subanalysis of a randomized trial.

Ramalingam S, Barstis J, Perry MC, La Rocca RV, Nattam SR, Rinaldi D, Clark R, Mills GM, Belani CP.

J Thorac Oncol. 2006 Mar;1(3):240-4.

27.

A gut reaction?

Ayirookuzhi SJ, Chintapalli N, Gu X, Mills GM.

Am J Med. 2007 Feb;120(2):143-5. No abstract available.

PMID:
17275453
28.

Phase II trial of gemcitabine as first line chemotherapy in patients with metastatic or unresectable soft tissue sarcoma.

Von Burton G, Rankin C, Zalupski MM, Mills GM, Borden EC, Karen A.

Am J Clin Oncol. 2006 Feb;29(1):59-61.

PMID:
16462504
29.

Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.

Williamson SK, Crowley JJ, Lara PN Jr, McCoy J, Lau DH, Tucker RW, Mills GM, Gandara DR; Southwest Oncology Group Trial S0003.

J Clin Oncol. 2005 Dec 20;23(36):9097-104.

PMID:
16361616
30.

Pathology case of the month. Young woman with arterial thrombosis. Heparin-induced thrombocytopenia and thrombosis (HITT).

Saccaro SJ, Veillon DM, Heldmann M, Hargon CG, Fried A, Mills GM, Cotelingam JD.

J La State Med Soc. 2005 May-Jun;157(3):130-4; quiz 134. No abstract available.

PMID:
16173311
31.

Head and neck cancer with simultaneous lung cancer.

Ampil FL, Mills GM, Heldmann M, Nathan CO.

J La State Med Soc. 2004 Jul-Aug;156(4):193-5.

PMID:
15366347
32.

Adenoma recurrences after resection of colorectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study.

Chu DZ, Chansky K, Alberts DS, Meyskens FL Jr, Fenoglio-Preiser CM, Rivkin SE, Mills GM, Giguere JK, Goodman GE, Abbruzzese JL, Lippman SM.

Ann Surg Oncol. 2003 Oct;10(8):870-5.

33.

Intratumoral cisplatin/epinephrine gel in advanced head and neck cancer: a multicenter, randomized, double-blind, phase III study in North America.

Castro DJ, Sridhar KS, Garewal HS, Mills GM, Wenig BL, Dunphy FR 2nd, Costantino PD, Leavitt RD, Stewart ME, Orenberg EK.

Head Neck. 2003 Sep;25(9):717-31.

PMID:
12953307
34.

Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation.

Belani CP, Barstis J, Perry MC, La Rocca RV, Nattam SR, Rinaldi D, Clark R, Mills GM.

J Clin Oncol. 2003 Aug 1;21(15):2933-9.

PMID:
12885812
35.

Positive response of advanced oropharyngeal cancer with trismus to chemoradiation.

Ampil FL, Mills GM, Nathan CO, Burton GV, Mansour R, Hardjasudarma M.

South Med J. 2003 Mar;96(3):316-7. No abstract available.

PMID:
12659368
36.
37.

The role of intratumoral therapy with cisplatin/epinephrine injectable gel in the management of advanced squamous cell carcinoma of the head and neck.

Wenig BL, Werner JA, Castro DJ, Sridhar KS, Garewal HS, Kehrl W, Pluzanska A, Arndt O, Costantino PD, Mills GM, Dunphy FR 2nd, Orenberg EK, Leavitt RD.

Arch Otolaryngol Head Neck Surg. 2002 Aug;128(8):880-5.

PMID:
12162764
38.

Induction chemotherapy followed by concomitant chemoradiation-induced regression of advanced cervical lymphadenopathy in head and neck cancer as a predictor of outcome.

Ampil FL, Mills GM, Caldito G, Burton GV, Nathan CO, Aarstad RF, Lian TF, Stucker FJ, Hardin JC Jr.

Otolaryngol Head Neck Surg. 2002 Jun;126(6):602-6.

PMID:
12087325
39.

A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy--Southwest Oncology Group study.

Whitehead RP, Unger JM, Flaherty LE, Kraut EH, Mills GM, Klein CE, Chapman RA, Doolittle GC, Hammond N, Sondak VK; Southwest Oncology Group.

Invest New Drugs. 2002 Feb;20(1):105-11.

40.

Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients.

Berenson JR, Crowley JJ, Grogan TM, Zangmeister J, Briggs AD, Mills GM, Barlogie B, Salmon SE.

Blood. 2002 May 1;99(9):3163-8.

41.

A retrospective study of metastatic lung cancer compression of the cauda equina.

Ampil FL, Mills GM, Burton GV.

Chest. 2001 Nov;120(5):1754-5. No abstract available.

PMID:
11713175
42.

Cauda equina compression in breast cancer--incidence and treatment outcome.

Ampil FL, Burton GV, Mills GM, Jawahar A, Pelser R, Nanda A.

Eur J Gynaecol Oncol. 2001;22(4):257-9.

PMID:
11695803
43.

Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II study.

Samlowski WE, Gundacker H, Kuebler JP, Giguere JK, Mills GM, Schuller DE, Ensley JF.

Invest New Drugs. 2001;19(4):311-5.

PMID:
11561690
44.

A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407).

Pienta KJ, Fisher EI, Eisenberger MA, Mills GM, Goodwin JW, Jones JA, Dakhil SR, Crawford ED, Hussain MH.

Prostate. 2001 Mar 1;46(4):257-61.

45.

Radical combined treatment of locally extensive head and neck cancer in the elderly.

Ampil FL, Mills GM, Stucker FJ, Burton GV, Nathan CO.

Am J Otolaryngol. 2001 Jan-Feb;22(1):65-9.

PMID:
11172217
46.

Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: a Southwest Oncology Group Study.

Gaynor ER, Unger JM, Miller TP, Grogan TM, White LA Jr, Mills GM, Balcerzak SP, Varterasian M, LeBlanc M, Fisher RI.

J Clin Oncol. 2001 Feb 1;19(3):750-5.

PMID:
11157027
47.

Cranial irradiation in patients with brain metastasis: a retrospective study of timing.

Ampil FL, Burton GV, Mills GM.

Radiat Med. 1999 Jul-Aug;17(4):271-3.

PMID:
10510899
48.
49.

Induction chemotherapy followed by concomitant chemoradiation for cervical esophageal cancer.

Ampil FL, Mills GM, Burton GV.

Am J Gastroenterol. 1999 Aug;94(8):2325-6. No abstract available.

PMID:
10445587
50.

Multiple myeloma metastatic to the thigh: successful treatment with radiation therapy.

Ampil FL, Mills GM, Burton GV, Heldmann M.

J La State Med Soc. 1999 Mar;151(3):136-7.

PMID:
10319606

Supplemental Content

Loading ...
Support Center